See also this year's filing and all EDGAR filings for this company.
PDF Report 0001062822_2026_Lexicon_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 318.25, 'aggregate_val': 49803000, 'exp_sum': 156000, 'exp_to_value': {'remainder_Revenues': 156000}} |
Graph
Absolute values for 0001062822, Lexicon Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,895,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,543,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,863,000 |
| 3 | remainder_Assets | 36,686,000 |
| 4 | LiabilitiesCurrent | 20,867,000 |
| 5 | LiabilitiesNoncurrent | 56,582,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 153,189 |
| 8 | SellingGeneralAndAdministrativeExpense | 40,314,004 |
| 9 | ResearchAndDevelopmentExpense | 67,344,596 |
| 10 | remainder_Expenses | 9,041,593 |
| 11 | remainder_Revenues | 44,123,160 |
| 12 | remainder_NetIncome | 8,773,818 |
| 13 | remainder_ComprehensiveNetIncome | -25,139 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 184,987,000 |
| 1 | Liabilities | 77,449,000 |
| 2 | Expenses | 116,853,382 |
| 3 | Revenues | 44,123,160 |
| 4 | StockholdersEquity | 107,538,000 |
| 5 | NetIncome | -63,956,404 |
| 6 | ComprehensiveNetIncome | -63,968,974 |
| 7 | BaseVar | 216,105,750 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.30 |
| 9 | EconomicCapitalRatio | 2.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
